Discover

QTTB
Q32 Bio Inc.
12.60
2 x 9.26
2 x 16.05
bid
ask
-
0.14
1.10%
2 @ 04:00 PM
12.85 +0.25 (1.98%)
Ytd279.52%
1y775.00%
12.43
day range
13.03
1.34
52 week range
15.02
Open12.87Prev Close12.74Low12.43High13.03Mkt Cap213.65M
Vol193.37KAvg Vol746.66KEPS2.78P/E4.53Forward P/E-0.60
BetaN/AShort Ratio6.74Inst. Own86.21%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-0650-d Avg9.11200-d Avg5.121yr Est17.40
Income Statement
Operating Expenses7.72M
Research and Development Expense3.22M
Selling, General and Administrative Expense4.50M
Operating Income-7.72M
Net Income-7.61M
Net Income Common Stock-7.61M
Net Income Common Stock (USD)-7.61M
Consolidated Income-7.61M
Earnings per Basic Share-0.54
Earnings per Basic Share (USD)-0.54
Earnings per Diluted Share-0.54
Earning Before Interest & Taxes (EBIT)-7.61M
Earning Before Interest & Taxes (USD)-7.61M
Weighted Average Shares14.10M
Weighted Average Shares Diluted14.10M
Balance Sheet
Cash and Equivalents51.40M
Cash and Equivalents (USD)51.40M
Current Assets57.20M
Property, Plant & Equipment Net5.83M
Total Assets63.68M
Debt Current6.24M
Total Debt12.93M
Current Liabilities10.67M
Debt Non-Current6.69M
Total Liabilities17.36M
Accumulated Retained Earnings (Deficit)-212.60M
Shareholders Equity46.31M
Shareholders Equity (USD)46.31M
Assets Non-Current6.47M
Total Debt (USD)12.93M
Liabilities Non-Current6.69M
Trade and Non-Trade Payables653.00K
Cash Flow
Depreciation, Amortization & Accretion253.00K
Net Cash Flow from Financing8.80M
Net Cash Flow / Change in Cash & Cash Equivalents2.45M
Issuance (Purchase) of Equity Shares10.36M
Issuance (Repayment) of Debt Securities -1.56M
Net Cash Flow from Operations-6.34M
Share Based Compensation1.55M